Forgot your USERNAME OR PASSWORD?
TCP LinkedIn Group
The 2015 Division for Translational and Clinical Pharmacology Annual Meeting will take place on Monday, March 30, from 5:30 to 6:30 PM in Room 107C of the Boston Convention & Exhibition Center.
Edited by Toshihisa Ishikawa, Richard B. Kim, and Jörg König. Click here to download a flyer with more information about the book. Dr. Kim is a member of ASPET.
Visit the UCSF-FDA TransPortal Data Index website. This site provides information on transporter expression, localization, substrates, inhibitors, and drug-drug interactions.
The year leading up to EB 2014 was an exciting one for the ISTCP division. As part of an effort to enhance recruitment and retention efforts, the division established a trainee focused task force led by...
The 2014 ISTCP best abstract award winners are...
Click here for a letter from ISTCP Secretary/Treasurer Jeffrey Paul detailing updated information about the Best Abstract Awards for graduate students and postdoctoral fellows.
Objective: The major goal of the ASPET Graduate &
Postdoctoral Award for Integrative Research in Pharmacology (ASPET-IRP
Award) is to provide support for graduate and postdoctoral trainees who
are involved in active research projects that involve in vivo pharmacology or are focused on organ systems as an integral part of their research efforts.
The TCP division's mission is to promote basic research translation to clinical utility (Bedside-to-Bench-to-Bedside) that will improve health and drive the discovery of new medicines to cure diseases.
To accomplish this, the division will 1) Organize Translational/Clinical Symposia on topics of relevance to ASPET members, 2) Highlight member’s research accomplishments and promote collaboration between academia, industry, and government, and 3) Provide resources for mentorship of members.
©The American Society for Pharmacology and Experimental Therapeutics (ASPET)9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.